![Pernilla Abrahamsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pernilla Abrahamsson
Directeur des opérations chez
LIPUM AB
Profil
Pernilla Abrahamsson is the founder of MD Biomedical AB. She is currently the Chief Operating Officer at Lipum AB. Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Postes actifs de Pernilla Abrahamsson
| Sociétés | Poste | Début |
|---|---|---|
| LIPUM AB | Directeur des opérations | 01/01/2019 |
Anciens postes connus de Pernilla Abrahamsson
| Sociétés | Poste | Fin |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01/04/2019 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Fondateur | - |
Formation de Pernilla Abrahamsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
Umea Universitet
 Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Health Services |
Lipum AB
 Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
